Skip to main content
SpringerLink
Log in

Cost studies still not being used at all levels of decision-making

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Meltzer MI.Health economics and prioritising health care. Lancet 372: 612-613, No. 9639, 23 Aug 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cost studies still not being used at all levels of decision-making. Pharmacoecon. Outcomes News 561, 2 (2008). https://doi.org/10.2165/00151234-200805610-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805610-00003

Keywords

Search

Navigation